AbbVie Inc. financial data

Symbol
ABBV on NYSE
Industry
Pharmaceutical Preparations
Location
1 North Waukegan Road, North Chicago, IL
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 81.2 % -13.8%
Quick Ratio 10.4 % -16.8%
Return On Equity 65.4 % +39.6%
Return On Assets 3.6 % -24.7%
Operating Margin 24.9 % -8.89%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.77B shares +0.09%
Entity Public Float 236B USD -12.2%
Weighted Average Number of Shares Outstanding, Basic 1.77B shares +0.11%
Weighted Average Number of Shares Outstanding, Diluted 1.77B shares +0.06%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 55.5B USD +0.72%
Costs and Expenses 41.7B USD +4.09%
Operating Income (Loss) 13.8B USD -8.25%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.2B USD -10.1%
Income Tax Expense (Benefit) 2.06B USD +39.3%
Net Income (Loss) Attributable to Parent 5.12B USD -21.4%
Earnings Per Share, Basic 2.88 USD/shares -21.3%
Earnings Per Share, Diluted 2.88 USD/shares -21.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.26B USD -45.4%
Accounts Receivable, after Allowance for Credit Loss, Current 11.5B USD +0.53%
Inventory, Net 4.45B USD +11.8%
Assets, Current 27.8B USD -16.4%
Property, Plant and Equipment, Net 5.14B USD +4.2%
Operating Lease, Right-of-Use Asset 744M USD +0.95%
Intangible Assets, Net (Excluding Goodwill) 66.6B USD +13.7%
Goodwill 35.3B USD +9.98%
Other Assets, Noncurrent 8.29B USD +16.8%
Assets 143B USD +5.29%
Accounts Payable, Current 3.69B USD +25.7%
Employee-related Liabilities, Current 1.8B USD +31.4%
Liabilities, Current 43.1B USD +23.8%
Long-term Debt and Lease Obligation 58.5B USD +5.17%
Accrued Income Taxes, Noncurrent 2.18B USD -26.9%
Deferred Income Tax Liabilities, Net 2.75B USD +34.5%
Operating Lease, Liability, Noncurrent 735M USD -2.52%
Other Liabilities, Noncurrent 33B USD +4.38%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.33B USD +0.81%
Retained Earnings (Accumulated Deficit) -4.96B USD -632%
Stockholders' Equity Attributable to Parent 6.03B USD -50.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.07B USD -49.9%
Liabilities and Equity 143B USD +5.29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.04B USD -3.65%
Net Cash Provided by (Used in) Financing Activities 10.8B USD
Net Cash Provided by (Used in) Investing Activities -9.59B USD -1821%
Common Stock, Shares Authorized 4B shares 0%
Common Stock, Shares, Issued 1.83B shares +0.49%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.25B USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.26B USD -45.4%
Deferred Tax Assets, Valuation Allowance 13.5B USD +40%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 19.9B USD +31.5%
Operating Lease, Liability 901M USD -2.07%
Depreciation 745M USD -2.1%
Payments to Acquire Property, Plant, and Equipment 193M USD +10.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.14B USD -32.4%
Lessee, Operating Lease, Liability, to be Paid 1.01B USD -2.23%
Property, Plant and Equipment, Gross 12.3B USD +7.96%
Operating Lease, Liability, Current 166M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169M USD +11.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -389M USD -45.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 107M USD -3.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 145M USD +11.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 5.76B USD +1.62%
Lessee, Operating Lease, Liability, to be Paid, Year Four 115M USD +1.77%
Amortization of Intangible Assets 7.59B USD -6.1%
Deferred Tax Assets, Net of Valuation Allowance 6.46B USD +16.7%
Share-based Payment Arrangement, Expense 872M USD +15.7%
Interest Expense 2.67B USD +19.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%